Last reviewed · How we verify
NCT05760560
Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex
trial testing Sugammadex in Postoperative Residual Curarization in 52 participants. Status unknown.
31 August 2023
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 52 |
| Start date | 15 March 2023 |
| Primary completion | 31 August 2023 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Sugammadex — full drug profile →
Conditions studied
- Postoperative Residual Curarization — all drugs for Postoperative Residual Curarization →
Sponsor
Seoul National University Hospital
Who can join
19 and older, any sex, with Postoperative Residual Curarization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study.
Koo CH, Lee S, Yim S, Bae YK, et al · · 2024 · cited 1× · PMID 39419348 · DOI 10.1016/j.accpm.2024.101445
Verify or expand the search:
- PubMed search for NCT05760560
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sugammadex
Trials testing the same drug.
- NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
- NCT07271875 — Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal Surgery · Phase 3 · not yet recruiting
- NCT07309393 — Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function · NA · recruiting
- NCT07203287 — Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease · Phase 4 · recruiting
- NCT06575036 — Sugammadex Dose Finding Under Two Years Old · Phase 2 · not yet recruiting
Other recruiting trials for Postoperative Residual Curarization
Currently open trials in the same condition.
- NCT06691204 — Comparison of Adductor Pollicis and Abductor Digiti Minimi Muscles (Thumb Vs. Fifth Digit) As Sites for Neuromuscular Mo · recruiting
- NCT06544980 — Measuring Upper Airway Cross Sectional Areas During Residual Neuromuscular Blockade and After Reserval · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05760560 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 14 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05760560.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing